Pricing Log in Create free account

Calidi Biotherapeutics, Inc. (CLDI) vs Decoy Therapeutics Inc (DCOY)

Calidi Biotherapeutics, Inc. and Decoy Therapeutics Inc are both Biotechnology companies. Calidi Biotherapeutics, Inc. and Decoy Therapeutics Inc are of similar size ($2.7M and $2.5M). Calidi Biotherapeutics, Inc. has the higher net margin (0.00% vs −698.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Decoy Therapeutics Inc leads on 8 and Calidi Biotherapeutics, Inc. on 5.

Valuation

Metric CLDI DCOY Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.29 9.40
P/B 0.32 0.14 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.08 0.49 0.66
EV/Sales n/m (3.49) 9.02
Earnings yield (7,757.14%) (5,122.62%) (32.88%)
Free cash flow yield (1,800.34%) (1,736.93%) (23.13%)

Profitability

Metric CLDI DCOY Biotechnology median
Gross margin — 10.57% 68.51%
Operating margin 0.00% (706.88%) 0.00%
Net margin 0.00% (698.79%) 0.00%
Free cash flow margin 0.00% (432.43%) 0.00%
Return on equity (900.56%) (827.77%) (51.96%)
Return on assets (283.36%) (278.04%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLDI DCOY Biotechnology median
Revenue growth (TTM) — (60.49%) 6.76%
EPS growth (last fiscal year) 83.31% 87.62% 29.88%
Revenue growth, 5-year CAGR — 12.73% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CLDI DCOY Biotechnology median
Debt to equity 0.24 0.00 0.00
Current ratio 1.68 1.83 4.97
Net debt to EBITDA 0.26 0.85 1.01

Dividend

Metric CLDI DCOY Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLDI DCOY Biotechnology median
Market cap 2.49m 2.67m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack